97 related articles for article (PubMed ID: 7850772)
1. Biodistribution of haematoporphyrin analogues in a lung carcinoma model.
Tronconi M; Colombo A; De Cesare M; Marchesini R; Woodburn KW; Reiss JA; Phillips DR; Zunino F
Cancer Lett; 1995 Jan; 88(1):41-8. PubMed ID: 7850772
[TBL] [Abstract][Full Text] [Related]
2. [The distribution of hematoporphyrin derivatives in the animal body].
Seĭlanov AS; Pyzhik VM; Seĭlanova IuA; Mironov AF; Deriuzhenko IV
Eksp Klin Farmakol; 1993; 56(4):48-50. PubMed ID: 8220018
[TBL] [Abstract][Full Text] [Related]
3. Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin components.
Tsuchida T; Zheng G; Pandey RK; Potter WR; Bellnier DA; Henderson BW; Kato H; Dougherty TJ
Photochem Photobiol; 1997 Aug; 66(2):224-8. PubMed ID: 9277141
[TBL] [Abstract][Full Text] [Related]
4. Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II.
Khanum F; Jain V
Indian J Exp Biol; 1997 Apr; 35(4):348-55. PubMed ID: 9315233
[TBL] [Abstract][Full Text] [Related]
5. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
[TBL] [Abstract][Full Text] [Related]
6. A preliminary pharmacokinetic study of intravenous Photofrin in patients.
Bellnier DA; Dougherty TJ
J Clin Laser Med Surg; 1996 Oct; 14(5):311-4. PubMed ID: 9612197
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic effects on the nuclear envelope of human skin fibroblasts.
Krammer B; Hubmer A; Hermann A
J Photochem Photobiol B; 1993 Feb; 17(2):109-14. PubMed ID: 8459315
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
9. Selective incorporation of 111In-labeled PHOTOFRIN by glioma tissue in vivo.
Whelan HT; Kras LH; Ozker K; Bajic D; Schmidt MH; Liu Y; Trembath LA; Uzum F; Meyer GA; Segura AD
J Neurooncol; 1994; 22(1):7-13. PubMed ID: 7714553
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
11. Binding of monomeric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity.
Sreenivasan R; Muruganandham M; Sharma M; Joshi PG; Joshi NB
Cancer Lett; 1997 Nov; 120(1):45-51. PubMed ID: 9570385
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
14. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice.
Gibson SL; Foster TH; Feins RH; Raubertas RF; Fallon MA; Hilf R
Br J Cancer; 1994 Mar; 69(3):473-81. PubMed ID: 8123476
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
Evensen JF; Sommer S; Rimington C; Moan J
Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
[TBL] [Abstract][Full Text] [Related]
16. Photofrin II as an efficient radiosensitizing agent in an experimental tumor.
Schaffer M; Schaffer PM; Corti L; Sotti G; Hofstetter A; Jori G; Dühmke E
Onkologie; 2001 Oct; 24(5):482-5. PubMed ID: 11694776
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.
Nelson JS; McCullough JL; Berns MW
J Natl Cancer Inst; 1988 Mar; 80(1):56-60. PubMed ID: 2963136
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors.
Tanaka M; Uchibayashi T; Obata T; Sasaki T
Cancer Lett; 1995 Apr; 90(2):163-9. PubMed ID: 7736452
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG).
Krosl G; Korbelik M
Cancer Lett; 1994 Aug; 84(1):43-9. PubMed ID: 8076362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
